Arrowhead Pharmaceuticals (ARWR)
(Delayed Data from NSDQ)
$24.67 USD
-0.47 (-1.87%)
Updated May 23, 2024 04:00 PM ET
After-Market: $24.69 +0.02 (0.08%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Arrowhead Pharmaceuticals, Inc. [ARWR]
Reports for Purchase
Showing records 61 - 80 ( 90 total )
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Focus on Nucleotide-based Therapy Positive
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Neutral Lowering to Neutral on reaching price target
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R